Depressive symptoms at age 9-13 and chronic disabling fatigue at age 16: A longitudinal study.


Journal

Journal of adolescence
ISSN: 1095-9254
Titre abrégé: J Adolesc
Pays: England
ID NLM: 7808986

Informations de publication

Date de publication:
08 2019
Historique:
received: 05 06 2019
revised: 29 07 2019
accepted: 30 07 2019
pubmed: 6 8 2019
medline: 13 6 2020
entrez: 6 8 2019
Statut: ppublish

Résumé

We investigated whether depressive symptoms at ages 9-13 years were associated with chronic disabling fatigue (CDF) at age 16 among children in the Avon Longitudinal Study of Parents & Children (ALSPAC) birth cohort. Depressive symptoms at ages 9, 10, 11, 12, and 13 years were defined as a child- or parent-completed Short Mood and Feelings Questionnaire (SMFQ) score ≥11 (range 0-26). SMFQ score was also analysed as a continuous exposure. Chronic disabling fatigue at 16 was defined as fatigue of ≥6 months' but <5 years' duration which prevented school attendance or activities, for which other causes were not identified, and with a Chalder Fatigue Questionnaire score ≥19. Logistic regression was used with multiple imputation to correct for missing data bias. We performed sensitivity analyses in which children who had CDF and depressive symptoms at age 16 were reclassified as not having CDF. In fully adjusted models using imputed data (N = 13,978), depressive symptoms at ages 9, 11, and 13 years were associated with 2- to 3-fold higher odds of CDF at age 16. Each one-point increase in SMFQ score at ages 9, 10, 11, 12, and 13 years was associated with 6-11% higher odds of CDF at age 16. Depressive symptoms and continuous SMFQ scores at each age were not associated with CDF if the outcome was reclassified to exclude children with comorbid depressive symptoms at age 16. Depressive symptoms at ages 9-13 were associated with chronic disabling fatigue at age 16, but causality is not certain.

Identifiants

pubmed: 31382113
pii: S0140-1971(19)30128-9
doi: 10.1016/j.adolescence.2019.07.014
pmc: PMC6706778
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

123-129

Subventions

Organisme : Department of Health
ID : SRF-2013-06-013
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_PC_19009
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/K020269/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_PC_15018
Pays : United Kingdom
Organisme : Department of Health
ID : DRF-2016-09-021
Pays : United Kingdom
Organisme : Medical Research Council
ID : G9815508
Pays : United Kingdom

Informations de copyright

Copyright © 2019 The Author(s). Published by Elsevier Ltd.. All rights reserved.

Références

J Am Acad Child Adolesc Psychiatry. 2000 Jan;39(1):28-38
pubmed: 10638065
J Child Psychol Psychiatry. 2002 Nov;43(8):1052-63
pubmed: 12455926
BMJ. 2003 Sep 20;327(7416):654-5
pubmed: 14500438
Am J Clin Nutr. 2004 Aug;80(2):525-6; author reply 526-7
pubmed: 15277181
Pediatrics. 2007 Mar;119(3):e603-9
pubmed: 17332180
BMJ. 2008 Jan 5;336(7634):26-9
pubmed: 18037616
Arch Pediatr Adolesc Med. 2008 May;162(5):469-75
pubmed: 18458194
J Psychosom Res. 2010 Jul;69(1):17-22
pubmed: 20630259
Arch Dis Child. 2011 Mar;96(3):211-4
pubmed: 20660520
Int J Public Health. 2010 Dec;55(6):701-3
pubmed: 20838848
Pediatrics. 2011 May;127(5):e1169-75
pubmed: 21502228
Int J Epidemiol. 2013 Feb;42(1):111-27
pubmed: 22507743
Pediatrics. 2012 Jul;130(1):e71-9
pubmed: 22711716
Arch Dis Child. 2013 Jun;98(6):425-8
pubmed: 23619200
BMC Fam Pract. 2014 Mar 07;15:44
pubmed: 24606913
Psychol Assess. 2014 Sep;26(3):752-62
pubmed: 24749755
BMC Med. 2014 Oct 01;12:167
pubmed: 25274261
J Adolesc Health. 2015 Feb;56(2):181-7
pubmed: 25448612
BMJ Open. 2015 Oct 28;5(10):e008830
pubmed: 26510728
Pediatrics. 2016 Feb;137(2):e20153434
pubmed: 26810786
Clin Child Psychol Psychiatry. 2017 Apr;22(2):326-340
pubmed: 27742756
Arch Dis Child. 2017 Jun;102(6):522-528
pubmed: 28104625
Clin Child Psychol Psychiatry. 2018 Jul;23(3):398-408
pubmed: 29096528
J Am Acad Child Adolesc Psychiatry. 1988 Nov;27(6):726-37
pubmed: 3058677
Clin Child Psychol Psychiatry. 2019 Jul;24(3):580-592
pubmed: 30945566
J Am Acad Child Adolesc Psychiatry. 1993 Jan;32(1):8-20
pubmed: 8428888
J Psychosom Res. 1993;37(2):147-53
pubmed: 8463991
Psychiatry Res. 1998 Nov 16;81(2):259-68
pubmed: 9858042
Epidemiology. 1999 Jan;10(1):37-48
pubmed: 9888278

Auteurs

Simon M Collin (SM)

Centre for Academic Child Health, University of Bristol, 1-5 Whiteladies Road, Bristol, BS8 1NU, UK.

Tom Norris (T)

School of Sport, Exercise and Health Sciences, Loughborough University, Epinal Way, Loughborough, LE11 3TU, UK.

Carol Joinson (C)

Centre for Academic Child Health, University of Bristol, 1-5 Whiteladies Road, Bristol, BS8 1NU, UK.

Maria E Loades (ME)

Centre for Academic Child Health, University of Bristol, 1-5 Whiteladies Road, Bristol, BS8 1NU, UK; Department of Psychology, University of Bath, Claverton Down, Bath, BA2 7AY, UK.

Glyn Lewis (G)

Division of Psychiatry, Faculty of Brain Sciences, University College London, London, W1T 7NF, UK.

Stephen A Stansfeld (SA)

Wolfson Institute of Preventive Medicine, Barts and The London School of Medicine and Dentistry, Charterhouse Square, London, EC1M 6BQ, UK.

Esther Crawley (E)

Centre for Academic Child Health, University of Bristol, 1-5 Whiteladies Road, Bristol, BS8 1NU, UK. Electronic address: esther.crawley@bristol.ac.uk.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH